U.S. Congressman John Culberson visits Celltex lab
Celltex proudly welcomed U.S. Congressman John Culberson, representative of the 7th District of Texas, to its offices in Houston, Texas. Celltex executive team members met with Culberson and presented him with Celltex updates and news, including partnerships for clinical research trials with Texas A&M Institute for Regenerative Medicine and Comisión Federal Para La Protección Contra Riesgos Sanitarios Comisión de Autorización Sanitaria (COFEPRIS), Mexico’s equivalent governmental regulatory body to the United States Food and Drug Administration (FDA).
Rep. Culberson also received a tour of Celltex’s state-of-the-art laboratory to observe how adult stem cells are processed in the lab, which is compliant with current Good Manufacturing Practice (cGMP) standards as recommended by the FDA for the manufacturing of biological products. He learned more about Celltex’s safety protocols and the safety testing that takes place each day to ensure the integrity of a client’s stem cells.
Celltex looks forward to working with Rep. Culberson on bringing stem cell therapy to the United States, in hopes that one day, millions of Americans in need will be able to access the regenerative power of their own adult stem cells for therapeutic purposes.
From left to right: David Eller, Celltex CEO, Chairman and Co-Founder; Congressman John Culberson; Dr. Jane Young, Celltex Chief Scientific Officer; Aditi Kaushik, Celltex Manufacturing Manager; Erik Eller, Celltex Vice President, Operations
More Recent News
Houston company gets green light to study your own stem cells to prevent COVID-19
Promising news out of Houston from a company that got the FDA’s clearance to try to use a person’s own stem cells to prevent COVID-19. Celltex Therapeutics Corporation is also hoping the stem cells will help treat some of the more severe cases.Read More
Former U.S. Secretary of Energy and Texas Governor, Rick Perry, Names Two Texas Companies as Leading Innovators in the Fight Against COVID-19
Celltex Therapeutics obtains approval from FDA to evaluate Celltex’s Mesenchymal Stem Cells as prevention against COVID-19 and Medistar Corporation’s biodefense HVAC filter to destroy nearly 100% of the virusRead More